PMC:7127386 / 9422-9569 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"236","span":{"begin":41,"end":56},"obj":"Disease"}],"attributes":[{"id":"A236","pred":"tao:has_database_id","subj":"236","obj":"MESH:D015658"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" inhibitor FDA approved for treatment of HIV-1 infection in combination with ritonavir 192725-17-0 49.75 25 26.63 26.10\nRitonavir protease inhibito"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T27","span":{"begin":41,"end":44},"obj":"Body_part"}],"attributes":[{"id":"A27","pred":"fma_id","subj":"T27","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":" inhibitor FDA approved for treatment of HIV-1 infection in combination with ritonavir 192725-17-0 49.75 25 26.63 26.10\nRitonavir protease inhibito"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T58","span":{"begin":47,"end":56},"obj":"Disease"}],"attributes":[{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":" inhibitor FDA approved for treatment of HIV-1 infection in combination with ritonavir 192725-17-0 49.75 25 26.63 26.10\nRitonavir protease inhibito"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T140","span":{"begin":1,"end":10},"obj":"Chemical"},{"id":"T141","span":{"begin":77,"end":86},"obj":"Chemical"}],"attributes":[{"id":"A140","pred":"chebi_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A141","pred":"chebi_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"}],"text":" inhibitor FDA approved for treatment of HIV-1 infection in combination with ritonavir 192725-17-0 49.75 25 26.63 26.10\nRitonavir protease inhibito"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T249","span":{"begin":1,"end":11},"obj":"DG_28"},{"id":"T250","span":{"begin":17,"end":25},"obj":"DG_23;CHEBI:31781;CHEBI:31781"},{"id":"T251","span":{"begin":55,"end":62},"obj":"CHEBI:4781;CHEBI:4781"},{"id":"T252","span":{"begin":63,"end":78},"obj":"CHEBI:50488;CHEBI:50488"},{"id":"T253","span":{"begin":91,"end":101},"obj":"SP_7"},{"id":"T254","span":{"begin":102,"end":107},"obj":"NCBITaxon:10239"},{"id":"T255","span":{"begin":129,"end":134},"obj":"NCBITaxon:10239"}],"text":" inhibitor FDA approved for treatment of HIV-1 infection in combination with ritonavir 192725-17-0 49.75 25 26.63 26.10\nRitonavir protease inhibito"}